Sage Journals: Discover world-class research

Retricted access

Research article

First published 2003-08

Oral interferon beta-1a in relapsing-remitting multiple sclerosis: a double-blind randomized study

C Polman, F Barkhof, L Kappos [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2018-10

A real-world comparison of relapse rates,healthcare costs and resource use among patients with multiple sclerosis newly initiating subcutaneous interferon beta-1a versus oral disease-modifying drugs

James D Bowen, Chris M Kozma, Megan M Grosso [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Retricted access

Other

First published 2008-03

Widespread maculopapular rash due to intramuscular interferon beta-1a during the treatment of multiple sclerosis

G. Serarslan, EE Okuyucu, IM Melek [...]

Multiple Sclerosis Journal

Free access

Other

First published 2010-01

A one-year prospective,randomized,placebo-controlled,quadruple-blinded,phase II safety pilot trial of combination therapy with interferon beta-1a and mycophenolate mofetil in early relapsing—remitting multiple sclerosis (TIME MS)

Gina M. Remington, Katherine Treadaway, Teresa Frohman [...]

Therapeutic Advances in Neurological Disorders

Open access

Research article

First published 2022-7

Fingolimod versus interferon beta 1-a: Benefit–harm assessment approach based on TRANSFORMS individual patient data

Alessandra Spanu, Hélène E Aschmann, Jürg Kesselring [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Free access

Other

First published 2010-01

A randomized,blinded,parallel-group,pilot trial of mycophenolate mofetil (CellCept) compared with interferon beta-1a (Avonex) in patients with relapsing-remitting multiple sclerosis

Elliot M. Frohman, Gary Cutter, Gina Remington [...]

Therapeutic Advances in Neurological Disorders

Retricted access

Research article

First published 2009-08

Randomized study of interferon beta-1a,low-dose azathioprine,and low-dose corticosteroids in multiple sclerosis

E Havrdova, R Zivadinov, J Krasensky [...]

Multiple Sclerosis Journal

Open access

Case report

First published 2022-1

Guanidinoacetate–creatine in secondary progressive multiple sclerosis: a case report

Sergej M. Ostojic, Jelena Ostojic, Dragana Zanini [...]

Journal of International Medical Research

Open access

Research article

First published 2014-5

Teriflunomide versus subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis: a randomised,controlled phase 3 trial

Patrick Vermersch, Anna Czlonkowska, Luigi ME Grimaldi [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2019

Real-life outcomes of teriflunomide treatment in patients with relapsing multiple sclerosis: TAURUS-MS observational study

Boris A. Kallmann, Klaus Tiel-Wilck, Jennifer S. Kullmann [...]

Therapeutic Advances in Neurological Disorders

Search results